273 studies found for:    Open Studies | "Stomach Diseases"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Stomach Diseases"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Screening for Stomach Diseases and Colorectal Neoplasms With the Fecal Testing
Conditions: Colorectal Cancer;   Stomach Disease
Interventions: Other: FIT(Eiken OC-Sensor) Two-day sampling;   Other: FIT(Eiken OC-Sensor) One-year interval;   Other: FIT(Eiken OC-Sensor) One-day sampling;   Other: FIT(Eiken OC-Sensor) Two-year interval;   Other: HpSA (Firstep Helicobacter pylori Antigen Rapid Test)
2 Recruiting Diagnosis of Gastric Lesions With Na-nose
Condition: Stomach Diseases
Intervention:
3 Recruiting Safety and Feasibility of TachoSil®: Application on Esophageal Anastomoses
Conditions: Esophageal Disease;   Gastric Disease
Intervention: Drug: Tachosil patch
4 Recruiting Effect of "Sekanjabin e Safarjali" (Quince Oxymel) in the Prevention of Migraine Attacks
Conditions: Migraine Headache;   Gastric Diseases
Interventions: Drug: propranolol;   Drug: Quince's oxymel;   Drug: placebo
5 Recruiting High Dose PPI Triple Therapy Versus Sequential Therapy for Helicobacter Pylori Eradication
Conditions: Dyspepsia;   Helicobacter-associated Gastritis;   Stomach Disorders
Interventions: Drug: Double dose of PPI;   Drug: sequence of drug use
6 Recruiting Effect of Early Oral Triple Viable Bifidobacterium Intestinal Flora in Preterm
Conditions: Disorder of Stomach Function and Feeding Problems in Newborn;   Feeding and Eating Disorders of Childhood
Interventions: Drug: Triple viable Bifidobacterium 0.5 bid po;   Dietary Supplement: early Micro-feeding
7 Unknown  Study on B-blockers to Prevent Decompensation of Cirrhosis With HTPortal
Conditions: Portal Hypertension Gastropathy;   Esophageal Varices;   Spontaneous Bacterial Peritonitis;   Hepatic Encephalopathy;   Ascites
Interventions: Drug: propranolol;   Drug: carvedilol;   Drug: placebo
8 Recruiting Domperidone for Refractory Gastrointestinal Disorders
Condition: Gastroparesis
Intervention: Drug: Domperidone
9 Recruiting Multicenter Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Men With Diabetic Gastroparesis
Condition: Diabetic Gastroparesis
Interventions: Drug: Metoclopramide Nasal Spray;   Drug: Placebo Nasal Spray
10 Recruiting Multicenter Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Women With Diabetic Gastroparesis
Condition: Diabetic Gastroparesis
Interventions: Drug: Metoclopramide Nasal Spray;   Drug: Placebo Nasal Spray
11 Unknown  Cytokine Gene Polymorphisms in Gastric Diseases
Conditions: Gastric Ulcer;   Duodenal Ulcer;   Gastric Cancer
Intervention: Procedure: IL-1, TNF-alpha, Il-10
12 Recruiting Study Evaluating Pyrotinib/Pyrotinib in Combination With Docetaxel in Patients With HER2+ Advanced Gastric Cancer
Condition: HER2 Positive Gastric Cancer
Intervention: Drug: Pyrotinib/Pyrotinib with Docetaxel
13 Recruiting Hemospray Versus the Combined Conventional Technique for Endoscopic Hemostasis of Bleeding Peptic Ulcers : A Pilot Study
Condition: Bleeding Peptic Ulcers
Interventions: Device: Hemospray;   Device: Combined Conventional Technique
14 Recruiting An Effect of an Individualized Physical Activity Intervention for Gastric Cancer Patient Undergoing Minimally Invasive Gastrectomy: a Phase III, Prospective Randomized Controlled Trial
Condition: Gastric Cancer
Intervention: Behavioral: physical activity intervention
15 Recruiting A Study to Evaluate the Effect of Camicinal on Gastroparesis Symptoms in Type 1 and 2 Diabetic Subjects With Gastroparesis
Condition: Gastroparesis
Interventions: Drug: Placebo;   Drug: Camicinal
16 Recruiting EVIDENCE: A Non-Interventional Study of Treatment and Clinical Outcomes in Chinese Patients With Gastric Cancer
Condition: Gastric Cancer
Intervention:
17 Recruiting Adjuvant Capecitabine Versus Observation Alone in Curatively Resected Stage IB Gastric Cancer
Condition: Gastric Cancer
Intervention: Drug: capecitabine
18 Unknown  Efficacy Study of Paclitaxel Versus Irinotecan in Patients With Recurrent or Metastatic Gastric Cancer Who Progress Following First-line Therapy
Condition: Gastric Cancer
Interventions: Drug: Paclitaxel;   Drug: Irinotecan
19 Recruiting Study of ONO-4538 in Unresectable Advanced or Recurrent Gastric Cancer
Condition: Gastric Cancer
Interventions: Drug: ONO-4538;   Drug: Placebo
20 Recruiting Vorinostat in Combination With Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection
Conditions: HIV Infection;   Recurrent Anal Cancer;   Recurrent Breast Cancer;   Recurrent Esophageal Cancer;   Recurrent Gastric Cancer;   Recurrent Metastatic Squamous Neck Cancer With Occult Primary;   Recurrent Non-small Cell Lung Cancer;   Recurrent Ovarian Epithelial Cancer;   Recurrent Salivary Gland Cancer;   Recurrent Squamous Cell Carcinoma of the Hypopharynx;   Recurrent Squamous Cell Carcinoma of the Larynx;   Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity;   Recurrent Squamous Cell Carcinoma of the Nasopharynx;   Recurrent Squamous Cell Carcinoma of the Oropharynx;   Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity;   Recurrent Verrucous Carcinoma of the Larynx;   Recurrent Verrucous Carcinoma of the Oral Cavity;   Salivary Gland Squamous Cell Carcinoma;   Stage IV Anal Cancer;   Stage IV Breast Cancer;   Stage IV Esophageal Cancer;   Stage IV Gastric Cancer;   Stage IV Non-small Cell Lung Cancer;   Stage IV Ovarian Epithelial Cancer;   Stage IV Salivary Gland Cancer;   Stage IV Squamous Cell Carcinoma of the Hypopharynx;   Stage IV Squamous Cell Carcinoma of the Larynx;   Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage IV Squamous Cell Carcinoma of the Nasopharynx;   Stage IV Squamous Cell Carcinoma of the Oropharynx;   Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity;   Stage IV Verrucous Carcinoma of the Larynx;   Stage IV Verrucous Carcinoma of the Oral Cavity;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: vorinostat;   Other: diagnostic laboratory biomarker analysis;   Other: pharmacological study;   Drug: carboplatin;   Drug: paclitaxel

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years